Glycomics Market: Current Analysis and Forecast (2021-2027)
Request Sample
Pre-order Enquiry
Request Customization
Check Discounts
Global Glycomics Market was valued at US$ XX billion in 2020 and is anticipated to reach US$ XX billion by 2027 displaying an elevated CAGR of XX% over the forecast period (2021-2027). Glycomics is a subset of the glycobiology field that deals in identifying the structure and function of the complete set of the glycome produced in a particular cell or organism and identify all the genes that encode glycoproteins. It is one of the rapidly emerging research fields highlighting functional aspects of glycans in biological systems.
The glycomics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. therefore, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on glycomic biomarkers as many recent studies suggest that glycan structure correlates with cancer development
With rapid technological advancement and rising investment in research & development of pharmaceutical & biotechnology companies, the glycomics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on Glycomics research owing to its wide scope of applications in drug discovery and development and other varied segments is propelling the growth of this market.
Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation are some of the prominent players operating in the global glycomics market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced Glycomics tools.
Insights Presented in the Report
“Amongst product, enzymes segment holds the major share”
Based on product, the market is fragmented into Enzymes, Instruments, Kits, Reagents, and Others. The enzymes segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F as enzymes are the proteins in the drug design that act as drug targets for various diseases in the process of drug discovery and development. In addition to this, the growth of this segment is also attributed to the wide scope of applications of enzymes in research related to cancer & diagnostics. The enzymes segment is also further sub-segmented into Glycosidases, Glycosyltransferases, Neuraminidases, Sialyltransferases, and others. Amongst these enzymes, glycosidases acquired the major market share owing to their use in oncology research.
“Amongst application, drug discovery & development is anticipated to grow at the highest CAGR during the analyzed period”
Based on application, the market is fragmented into diagnostics, drug discovery and development, and others. The drug discovery & development segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the rising potential of glycomics in the identification of biomarkers and increase in demand for glycomics products in drug discovery & development as glycan chains can be modified to synthesize various drugs. For example, a naturally occurring disaccharide unit of glycosaminoglycan known as hyaluronan has wide applications in medicine as it is used in post-surgical wounds.
Amongst end-user, academic research institutes segment holds the major share”
Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, clinical laboratories, academic research institutes, and others. The academic research institutes segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing number of collaborations between key industry players and academic research institutes. However, the pharmaceutical & biotechnology companies segment is expected to grow at a highest CAGR of XX% due to the increase in the number of pharmaceutical & biotechnology companies. For instance, according to India Brand Equity Foundation, the domestic pharmaceutical industry in India includes a network of 3,000 drug companies and nearly 10,500 manufacturing units.
“North America signifies one of the largest markets of glycomics Market”
For a better understanding of the market dynamics of the glycomics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to period owing to wide adoption of Glycomics tools and growing awareness among researchers regarding its application in the early detection of cancer. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The glycomics market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
The glycomics market is growing exponentially on account of growth in mortality rates and incidences of cancer and other chronic diseases coupled with the heavy demand for medicines across the world. For instance, according to the World Health Organization, cancer is one of the leading causes of death globally, accounting for nearly 9.6 million deaths in 2018. this number has been increased and has reached around 10 million deaths globally in 2020. therefore, scientists across the world are carrying out high-level research on cancer therapeutics and diagnostics including research on glycomic biomarkers as many recent studies suggest that glycan structure correlates with cancer development
With rapid technological advancement and rising investment in research & development of pharmaceutical & biotechnology companies, the glycomics market is witnessing an uptick all over the globe. For instance, The Pharmaceutical Research and Manufacturers of America (PhRMA) trade group represents the leading biopharmaceutical research companies in the United States. In 2019, the research and development (R&D) expenditure of its member companies reached USD 83 billion worldwide, up from USD 79.6 billion in 2018. Furthermore, the growing focus on Glycomics research owing to its wide scope of applications in drug discovery and development and other varied segments is propelling the growth of this market.
Thermo Fisher Scientific, Agilent Technologies, Danaher, Merck KGaA, RayBiotech, Shimadzu Corporation, Takara Bio, New England Biolabs, S-BIO, Waters Corporation are some of the prominent players operating in the global glycomics market. Several M&A’s along with partnerships have been undertaken by these players to develop new and advanced Glycomics tools.
Insights Presented in the Report
“Amongst product, enzymes segment holds the major share”
Based on product, the market is fragmented into Enzymes, Instruments, Kits, Reagents, and Others. The enzymes segment generated revenue of USD XX million in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F as enzymes are the proteins in the drug design that act as drug targets for various diseases in the process of drug discovery and development. In addition to this, the growth of this segment is also attributed to the wide scope of applications of enzymes in research related to cancer & diagnostics. The enzymes segment is also further sub-segmented into Glycosidases, Glycosyltransferases, Neuraminidases, Sialyltransferases, and others. Amongst these enzymes, glycosidases acquired the major market share owing to their use in oncology research.
“Amongst application, drug discovery & development is anticipated to grow at the highest CAGR during the analyzed period”
Based on application, the market is fragmented into diagnostics, drug discovery and development, and others. The drug discovery & development segment generated revenue of USD XX million in 2020. The segment is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the rising potential of glycomics in the identification of biomarkers and increase in demand for glycomics products in drug discovery & development as glycan chains can be modified to synthesize various drugs. For example, a naturally occurring disaccharide unit of glycosaminoglycan known as hyaluronan has wide applications in medicine as it is used in post-surgical wounds.
Amongst end-user, academic research institutes segment holds the major share”
Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, clinical laboratories, academic research institutes, and others. The academic research institutes segment generated revenue of USD XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX million by 2027F owing to the growing number of collaborations between key industry players and academic research institutes. However, the pharmaceutical & biotechnology companies segment is expected to grow at a highest CAGR of XX% due to the increase in the number of pharmaceutical & biotechnology companies. For instance, according to India Brand Equity Foundation, the domestic pharmaceutical industry in India includes a network of 3,000 drug companies and nearly 10,500 manufacturing units.
“North America signifies one of the largest markets of glycomics Market”
For a better understanding of the market dynamics of the glycomics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX million in 2020 owing to period owing to wide adoption of Glycomics tools and growing awareness among researchers regarding its application in the early detection of cancer. At the same time, Asia-Pacific is anticipated to grow at the highest CAGR of XX% during the forecast period.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The glycomics market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Details
UMI-18826135
30-Jul-2021
152
30-Jul-2021
152
License
